Toward the reliable diagnosis of indeterminate thyroid lesions: A HRMAS NMR-based metabolomics case of study

Journal of Proteome Research

Volumn 11, Issue 6, 2012, Pages 3317-3325

  Torregrossa, Liborio ^a   Shintu, Laetitia ^b   Nambiath Chandran, Jima ^b   Tintaru, Aura ^c   Ugolini, Clara ^a   Magalhães, Alviclér ^d   Basolo, Fulvio ^a   Miccoli, Paolo ^a   Caldarelli, Stefano ^b,e  

^a UNIVERSITY OF PISA   (Italy)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c AIX MARSEILLE UNIV   (France)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

Author keywords

HRMAS NMR; indeterminate; metabolomics; thyroid cancer

Indexed keywords

CHOLINE; INOSITOL DERIVATIVE; LACTIC ACID; PHENYLALANINE; TAURINE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CHILD; CONTROLLED STUDY; CYTOLOGY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; THYROID CANCER; TUMOR DIFFERENTIATION; ADENOCARCINOMA, FOLLICULAR; ADENOMA; DIFFERENTIAL DIAGNOSIS; METABOLISM; METABOLOME; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY; THYROID NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84861799754     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300105e     Document Type: Article

References (43)

1. Hodgson, N. C.; Button, J.; Solorzano, C. C. Thyroid cancer: is the incidence still increasing? Ann. Surg. Oncol. 2004, 11 (12) 1093-7
2. Davies, L.; Welch, H. G. Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA, J. Am. Med. Assoc. 2006, 295 (18) 2164-7
3. Mazzaferri, E. L. Management of a solitary thyroid nodule N. Engl. J. Med. 1993, 328 (8) 553-9
4. Castro, M. R.; Gharib, H. Continuing controversies in the management of thyroid nodules Ann. Intern. Med. 2005, 142 (11) 926-31
5. Cooper, D. S.; Doherty, G. M.; Haugen, B. R.; Kloos, R. T.; Lee, S. L.; Mandel, S. J.; Mazzaferri, E. L.; McIver, B.; Sherman, S. I.; Tuttle, R. M. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 2006, 16 (2) 109-42
6. Giordano, T. J.; Kuick, R.; Thomas, D. G.; Misek, D. E.; Vinco, M.; Sanders, D.; Zhu, Z.; Ciampi, R.; Roh, M.; Shedden, K.; Gauger, P.; Doherty, G.; Thompson, N. W.; Hanash, S.; Koenig, R. J.; Nikiforov, Y. E. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis Oncogene 2005, 24 (44) 6646-56
7. Nikiforov, Y. E.; Steward, D. L.; Robinson-Smith, T. M.; Haugen, B. R.; Klopper, J. P.; Zhu, Z.; Fagin, J. A.; Falciglia, M.; Weber, K.; Nikiforova, M. N. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules J. Clin. Endocrinol. Metab. 2009, 94 (6) 2092-8
8. Pizzolanti, G.; Russo, L.; Richiusa, P.; Bronte, V.; Nuara, R. B.; Rodolico, V.; Amato, M. C.; Smeraldi, L.; Sisto, P. S.; Nucera, M.; Bommarito, A.; Citarrella, R.; Lo Coco, R.; Cabibi, D.; Lo Coco, A.; Frasca, F.; Gulotta, G.; Latteri, M. A.; Modica, G.; Galluzzo, A.; Giordano, C. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement Thyroid 2007, 17 (11) 1109-15
9. Xing, M.; Tufano, R. P.; Tufaro, A. P.; Basaria, S.; Ewertz, M.; Rosenbaum, E.; Byrne, P. J.; Wang, J.; Sidransky, D.; Ladenson, P. W. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer J. Clin. Endocrinol. Metab. 2004, 89 (6) 2867-72
10. Sapio, M. R.; Guerra, A.; Posca, D.; Limone, P. P.; Deandrea, M.; Motta, M.; Troncone, G.; Caleo, A.; Vallefuoco, P.; Rossi, G.; Fenzi, G.; Vitale, M. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma Endocr.-Relat. Cancer 2007, 14 (4) 1089-97
11. Filicori, F.; Keutgen, X. M.; Buitrago, D.; AlDailami, H.; Crowley, M.; Fahey, T. J., 3rd; Zarnegar, R. Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis Surgery 2011, 150 (6) 1085-91
12. Nikiforov, Y. E.; Ohori, N. P.; Hodak, S. P.; Carty, S. E.; LeBeau, S. O.; Ferris, R. L.; Yip, L.; Seethala, R. R.; Tublin, M. E.; Stang, M. T.; Coyne, C.; Johnson, J. T.; Stewart, A. F.; Nikiforova, M. N. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples J. Clin. Endocrinol. Metab. 2011, 96 (11) 3390-7
13. Zatelli, M. C.; Trasforini, G.; Leoni, S.; Frigato, G.; Buratto, M.; Tagliati, F.; Rossi, R.; Cavazzini, L.; Roti, E.; degli Uberti, E. C. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies Eur. J. Endocrinol. 2009, 161 (3) 467-73
14. Sapio, M. R.; Posca, D.; Raggioli, A.; Guerra, A.; Marotta, V.; Deandrea, M.; Motta, M.; Limone, P. P.; Troncone, G.; Caleo, A.; Rossi, G.; Fenzi, G.; Vitale, M. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings Clin. Endocrinol. (Oxford, U. K.) 2007, 66 (5) 678-83
15. Bartolazzi, A.; Orlandi, F.; Saggiorato, E.; Volante, M.; Arecco, F.; Rossetto, R.; Palestini, N.; Ghigo, E.; Papotti, M.; Bussolati, G.; Martegani, M. P.; Pantellini, F.; Carpi, A.; Giovagnoli, M. R.; Monti, S.; Toscano, V.; Sciacchitano, S.; Pennelli, G. M.; Mian, C.; Pelizzo, M. R.; Rugge, M.; Troncone, G.; Palombini, L.; Chiappetta, G.; Botti, G.; Vecchione, A.; Bellocco, R. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study Lancet Oncol. 2008, 9 (6) 543-9
16. Franco, C.; Martinez, V.; Allamand, J. P.; Medina, F.; Glasinovic, A.; Osorio, M.; Schachter, D. Molecular markers in thyroid fine-needle aspiration biopsy: a prospective study Appl. Immunohistochem. Mol. Morphol. 2009, 17 (3) 211-5
17. Vriens, M. R.; Weng, J.; Suh, I.; Huynh, N.; Guerrero, M. A.; Shen, W. T.; Duh, Q. Y.; Clark, O. H.; Kebebew, E. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 2011, not supplied.
18. Keutgen, X. M.; Filicori, F.; Crowley, M. J.; Wang, Y.; Scognamiglio, T.; Hoda, R.; Buitrago, D.; Cooper, D.; Zeiger, M. A.; Zarnegar, R.; Elemento, O.; Fahey, T. J., 3rd A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin. Cancer Res. 2012, not supplied.
19. Brown, L. M.; Helmke, S. M.; Hunsucker, S. W.; Netea-Maier, R. T.; Chiang, S. A.; Heinz, D. E.; Shroyer, K. R.; Duncan, M. W.; Haugen, B. R. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue Mol. Carcinog. 2006, 45 (8) 613-26
20. Krause, K.; Jessnitzer, B.; Fuhrer, D. Proteomics in thyroid tumor research J. Clin. Endocrinol. Metab. 2009, 94 (8) 2717-24
21. Fan, Y.; Shi, L.; Liu, Q.; Dong, R.; Zhang, Q.; Yang, S.; Yang, H.; Wu, P.; Yu, J.; Zheng, S.; Yang, F.; Wang, J. Discovery and identification of potential biomarkers of papillary thyroid carcinoma Mol. Cancer 2009, 8, 79
22. Linkov, F.; Ferris, R. L.; Yurkovetsky, Z.; Marrangoni, A.; Velikokhatnaya, L.; Gooding, W.; Nolan, B.; Winans, M.; Siegel, E. R.; Lokshin, A.; Stack, B. C., Jr. Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases Proteomics Clin. Appl. 2008, 2 (12) 1575-85
23. Russell, P.; Lean, C. L.; Delbridge, L.; May, G. L.; Dowd, S.; Mountford, C. E. Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms Am. J. Med. 1994, 96 (4) 383-8
24. Lean, C. L.; Delbridge, L.; Russell, P.; May, G. L.; Mackinnon, W. B.; Roman, S.; Fahey, T. J., 3rd; Dowd, S.; Mountford, C. E. Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy J. Clin. Endocrinol. Metab. 1995, 80 (4) 1306-11
25. Fadda, G.; Basolo, F.; Bondi, A.; Bussolati, G.; Crescenzi, A.; Nappi, O.; Nardi, F.; Papotti, M.; Taddei, G.; Palombini, L. Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group Pathologica 2010, 102 (5) 405-8
26. Sadek, M.; Brownlee, R. T. C.; Scrofani, S. D. B.; Wedd, A. G. Tocsy Assignment of Broad Resonances in Paramagnetic Proteins J. Magn. Reson., Ser. B 1993, 101 (3) 309-14
27. Sansone, S. A.; Fan, T.; Goodacre, R.; Griffin, J. L.; Hardy, N. W.; Kaddurah-Daouk, R.; Kristal, B. S.; Lindon, J.; Mendes, P.; Morrison, N.; Nikolau, B.; Robertson, D.; Sumner, L. W.; Taylor, C.; van der Werf, M.; van Ommen, B.; Fiehn, O. The metabolomics standards initiative Nat. Biotechnol. 2007, 25 (8) 844-48
28. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs; DeLellis, R. A.; Lloyd, R. V.; Heitz, P. U. Eng, C., Eds.; IARC Press: Lyon, 2004.
29. Bax, A. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy J. Magn. Reson. 1985, 65 (2) 142-45
30. Keeler, J. Understanding NMR Spectroscopy, 2 nd ed.; John Wiley and Sons: Chichester, U.K., 2010.
31. Nicholson, J. K.; Foxall, P. J. D.; Spraul, M.; Farrant, R. D.; Lindon, J. C. 750-MHz H-1 and H-1-C-13 NMR-spectroscopy of human blood-plasma Anal. Chem. 1995, 67 (5) 793-811
32. Fan, T. W.-M. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures Prog. Nucl. Magn. Reson. Spectrosc. 1996, 28 (2) 161-219
33. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS) J. Chemom. 2002, 16, 119-28
34. Delbridge, L.; Lean, C. L.; Russell, P.; May, G. L.; Roman, S.; Dowd, S.; Reeve, T. S.; Mountford, C. E. Proton magnetic resonance and human thyroid neoplasia. II: Potential avoidance of surgery for benign follicular neoplasms World J. Surg. 1994, 18 (4) 512-6 discussion 16-7
35. Chan, E. C.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS) J. Proteome Res. 2009, 8 (1) 352-61
36. Kuemmerle, N. B.; Rysman, E.; Lombardo, P. S.; Flanagan, A. J.; Lipe, B. C.; Wells, W. A.; Pettus, J. R.; Froehlich, H. M.; Memoli, V. A.; Morganelli, P. M.; Swinnen, J. V.; Timmerman, L. A.; Chaychi, L.; Fricano, C. J.; Eisenberg, B. L.; Coleman, W. B.; Kinlaw, W. B. Lipoprotein lipase links dietary fat to solid tumor cell proliferation Mol. Cancer Ther. 2011, 10 (3) 427-36
37. Brizel, D. M.; Schroeder, T.; Scher, R. L.; Walenta, S.; Clough, R. W.; Dewhirst, M. W.; Mueller-Klieser, W. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer Int. J. Radiat. Oncol. 2001, 51 (2) 349-53
38. Walenta, S.; Schroeder, T.; Mueller-Klieser, W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology Curr. Med. Chem. 2004, 11 (16) 2195-204
39. Tessem, M. B.; Selnaes, K. M.; Sjursen, W.; Trano, G.; Giskeodegard, G. F.; Bathen, T. F.; Gribbestad, I. S.; Hofsli, E. Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis J. Proteome Res. 2010, 9 (7) 3664-70
40. Tessem, M. B.; Swanson, M. G.; Keshari, K. R.; Albers, M. J.; Joun, D.; Tabatabai, Z. L.; Simko, J. P.; Shinohara, K.; Nelson, S. J.; Vigneron, D. B.; Gribbestad, I. S.; Kurhanewicz, J. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using H-1 HR-MAS spectroscopy of biopsy tissues Magn. Reson. Med. 2008, 60 (3) 510-16
41. Koppenol, W. H.; Bounds, P. L.; Dang, C. V. Otto Warburg's contributions to current concepts of cancer metabolism Nat Rev Cancer 2011, 11 (5) 325-37
42. Raffelt, K.; Moka, D.; Sullentrop, F.; Dietlein, M.; Hahn, J.; Schicha, H. Systemic alterations in phospholipid concentrations of blood plasma in patients with thyroid carcinoma: an in-vitro P-31 high-resolution NMR study NMR Biomed. 2000, 13 (1) 8-13
43. Charles, E. M. Basic principles of ROC analysis Semin. Nucl. Med. 1978, 8 (4) 283-98